SCHAUMBURG, Ill., June 24, 2011 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT) today announced that chief executive officer, founder and chairman of the board Jeffrey M. Yordon received the Ernst & Young Entrepreneur Of The Year® 2011 Midwest Award in the health sciences category. According to Ernst & Young LLP, the award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.
As a Midwest region award winner, Mr. Yordon is now eligible for consideration for the Ernst & Young Entrepreneur Of The Year 2011 National Award. Award winners in several national categories, as well as the overall Ernst & Young Entrepreneur Of The Year National Award winner, will be announced at the annual awards gala in Palm Springs, California, on November 12, 2011.
Mr. Yordon, a pharmaceutical industry veteran, founded Sagent Pharmaceuticals in 2006. Since its founding, the company has launched 24 generic injectable products and recently completed its initial public offering.
During his career, Mr. Yordon has held executive leadership positions at American Pharmaceutical Partners, Gensia Laboratories, Faulding Pharmaceuticals and LyphoMed, Inc. Mr. Yordon received a bachelor's degree from Northern Illinois University.
About Ernst & Young Entrepreneur Of The Year®
Ernst & Young Entrepreneur Of The Year® is the world's most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential, and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 140 cities in more than 50 countries.
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent operates a global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, which quickly yields an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients.
To learn more about Sagent, please visit www.SagentPharma.com.